Federal
Supporting the goals to protect United States military personnel from malaria.
Source: Congress.gov ·
815 words in original text
Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
IV
116TH CONGRESS
1ST SESSION
H. RES. 214
Supporting the goals to protect United States military personnel from malaria.
IN THE HOUSE OF REPRESENTATIVES
MARCH 11, 2019
Mr. PANETTA (for himself and Mr. MAST) submitted the following resolution;
which was referred to the Committee on Foreign Affairs, and in addition
to the Committees on Armed Services, and Energy and Commerce, for
a period to be subsequently determined by the Speaker, in each case for
consideration of such provisions as fall within the jurisdiction of the com-
mittee concerned
RESOLUTION
Supporting the goals to protect United States military
personnel from malaria.
Whereas fighting malaria is in the national interest of the
United States;
Whereas reducing the incidence of malaria protects United
States servicemembers deployed to malaria-endemic re-
gions;
Whereas the ‘‘World malaria report 2018’’ by the World
Health Organization states that, in 2017, approximately
435,000 people died of malaria;
VerDate Sep 11 2014
01:43 Mar 12, 2019
Jkt 089200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR214.IH
HR214
pamtmann on DSKBFK8HB2PROD with BILLS
2
•HRES 214 IH
Whereas, in 2018, 87 countries and areas had ongoing ma-
laria transmissions, including areas of Africa, the Middle
East, and South Africa;
Whereas the Department of Defense reports that a total of
60 servicemembers were diagnosed with malaria in 2016,
the highest number since 2011;
Whereas incidents of malaria were diagnosed at or reported
from 19 different medical facilities in the United States,
Afghanistan, Qatar, Germany, Djibouti, Japan, and
South Korea in 2017;
Whereas the Department of Defense recognizes malaria as
the number one infectious disease threat to United States
military forces;
Whereas United States support for efforts to fight malaria is
in the foreign policy and humanitarian interests of the
United States and highlights the values of the people of
the United States through the work of governmental,
nongovernmental, and faith-based organizations of the
United States that are on the frontlines of the malaria
battle globally;
Whereas United States support for efforts to fight malaria
and other infectious diseases advance the United States
National Security Strategy, and is a key tool to enhance
operational readiness, interoperability, and security co-
operation, protecting Americans at home and abroad;
Whereas the United States Government has played a leading
role in the recent progress made toward reducing the
global burden of malaria and other infectious diseases,
particularly through bilateral, multilateral, international,
and civil society partners;
VerDate Sep 11 2014
01:43 Mar 12, 2019
Jkt 089200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HR214.IH
HR214
pamtmann on DSKBFK8HB2PROD with BILLS
3
•HRES 214 IH
Whereas, since 1893, the Walter Reed Army Institute of Re-
search (WRAIR) has played a leadership role protecting
United States servicemembers from the world’s most per-
vasive infectious diseases, including malaria, HIV/AIDS,
Ebola, and dengue;
Whereas WRAIR Center for Infectious Disease Research has
been responsible for developing critical Food and Drug
Administration-approved medicines, vaccines, drugs, and
other interventions used to prevent malaria, Japanese en-
cephalitis, hepatitis A, adenovirus, and other infectious
diseases in deployed servicemembers;
Whereas the WRAIR Malaria Vaccine and Experimental
Therapeutics Branches have emerged as the Department
of Defense’s premier effort to develop vaccines and drugs
to protect the warfighter from malaria and other infec-
tious diseases and military health threats;
Whereas WRAIR continues to play a leadership role in the
research and development of lifesaving medicines includ-
ing the recently approved tafenoquine, a radical cure and
prophylaxis that protects the warfighter from P vivax re-
lapse, a condition that causes approximately 8.5 million
clinical infections per year worldwide;
Whereas WRAIR leads the fight against drug-resistant
strains of malaria, developing new treatments that have
revolutionized malaria prevention efforts;
Whereas WRAIR’s international network of laboratories sup-
ports medical diplomacy and fosters United States-host
nation collaborations in biomedical research; and
Whereas WRAIR’s unique expertise, capabilities, and re-
sources have led to historic clinical trials, testing vaccines
VerDate Sep 11 2014
01:43 Mar 12, 2019
Jkt 089200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6300
E:\BILLS\HR214.IH
HR214
pamtmann on DSKBFK8HB2PROD with BILLS
4
•HRES 214 IH
to prevent the spread of HIV/AIDS, zika, and malaria:
Now, therefore, be it
Resolved, That the House of Representatives—
1
(1) supports the goals of researching new inter-
2
ventions to prevent and treat malaria, as it is in the
3
national security, foreign affairs, political, and hu-
4
manitarian interest of the United States;
5
(2) encourages continued leadership by the
6
United States through programs such as the Walter
7
Reed Army Institute of Research to ensure that the
8
health of the Force is not jeopardized by vector-
9
borne diseases; and
10
(3) supports sustained or enhanced efforts so
11
that once eliminated in a country, malaria does not
12
return.
13
Æ
VerDate Sep 11 2014
01:43 Mar 12, 2019
Jkt 089200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\HR214.IH
HR214
pamtmann on DSKBFK8HB2PROD with BILLS
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.